Immunology and Microbiology
Development
100%
Vaccine Efficacy
100%
Otitis Media
100%
Human Respiratory Syncytial Virus
100%
Virus
50%
Infectious Agent
16%
Age
16%
Liquid
16%
Middle Ear
16%
Respiratory Syncytial Virus Infection
16%
Lower Respiratory Tract
16%
Respiratory Syncytial Virus Vaccine
16%
Keyphrases
Vaccine Development
100%
Otitis Media
100%
Respiratory Syncytial Virus
100%
Virus
50%
Respiratory Syncytial Virus Infection
16%
Middle Ear Fluid
16%
Bacterial Pathogens
16%
Lower Respiratory Tract Infection
16%
Virologic
16%
Pediatric Diseases
16%
Older children
16%
Respiratory Syncytial Virus Vaccines
16%
Nasal Wash
16%
One Percent
16%
Pharmacology, Toxicology and Pharmaceutical Science
Vaccine Development
100%
Human Respiratory Syncytial Virus
100%
Acute Otitis Media
100%
Virus
50%
Diseases
16%
Infection
16%
Vaccine
16%
Infectious Agent
16%
Respiratory Syncytial Virus Infection
16%
Lower Respiratory Tract Infection
16%
Respiratory Syncytial Virus Vaccine
16%
INIS
vaccines
100%
viruses
100%
children
55%
diseases
11%
fluids
11%
pathogens
11%
pediatrics
11%
infants
11%
values
11%
ears
11%
nose
11%
Medicine and Dentistry
Respiratory Syncytial Virus Vaccine
16%